Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank57
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-134.01M
Near historical average
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-122.59M
Historical baseline
PeriodValueYoY Change
TTM$-134.01M+21.6%
2024$-170.86M+17.8%
2023$-207.82M-26.9%
2022$-163.75M-6.3%
2021$-154.09M-77.5%
2020$-86.83M-121.8%
2019$-39.14M-61.4%
2018$-24.25M-